Manufacturers set list prices for their brand-name drugs; those are the eye-popping figures that have sent Congress and presidential candidates into fits of outrage.
But almost no one actually pays those prices. Insurers and pharmacy-benefit managers, who manage drug plans for insurers, negotiate discounts and rebates, which lowers the effective cost of a drug. And they have been getting better at doing this.
Read Full Article »
